Work

Early versus delayed autologous stem cell transplant (ASCT) in patients receiving induction therapy with lenalidomide, bortezomib, and dexamethasone (RVD) for newly diagnosed multiple myeloma (MM).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.8540

Authors: Ajay K. Nooka, Amelia A. Langston, Edmund K. Waller, Leonard T. Heffner, Charise Gleason, Samatha Muppidi, Melanie Watson, Daniela Casbourne, Lawrence Boise, Jonathan L. Kaufman, Sagar Lonial

Institutions: Emory University, Winship Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2470933183

Cites:

Cited by: 2

Related to: 10